150 related articles for article (PubMed ID: 21292671)
1. Restoration of T cell responses to toxoplasma gondii after successful combined antiretroviral therapy in patients with AIDS with previous toxoplasmic encephalitis.
Lejeune M; Miró JM; De Lazzari E; García F; Claramonte X; Martínez E; Ribera E; Arrizabalaga J; Arribas JR; Domingo P; Ferrer E; Plana M; Valls ME; Podzamczer D; Pumarola T; Jacquet A; Mallolas J; Gatell JM; Gallart T;
Clin Infect Dis; 2011 Mar; 52(5):662-70. PubMed ID: 21292671
[TBL] [Abstract][Full Text] [Related]
2. Restoration of Toxoplasma gondii-specific immune responses in patients with AIDS starting HAART.
Furco A; Carmagnat M; Chevret S; Garin YJ; Pavie J; De Castro N; Charron D; Derouin F; Rabian C; Molina JM
AIDS; 2008 Oct; 22(16):2087-96. PubMed ID: 18832872
[TBL] [Abstract][Full Text] [Related]
3. Evolving characteristics of toxoplasmosis in patients infected with human immunodeficiency virus-1: clinical course and Toxoplasma gondii-specific immune responses.
Hoffmann C; Ernst M; Meyer P; Wolf E; Rosenkranz T; Plettenberg A; Stoehr A; Horst HA; Marienfeld K; Lange C
Clin Microbiol Infect; 2007 May; 13(5):510-5. PubMed ID: 17298486
[TBL] [Abstract][Full Text] [Related]
4. Immune recovery under highly active antiretroviral therapy is associated with restoration of lymphocyte proliferation and interferon-gamma production in the presence of Toxoplasma gondii antigens.
Fournier S; Rabian C; Alberti C; Carmagnat MV; Garin JF; Charron D; Derouin F; Molina JM
J Infect Dis; 2001 Jun; 183(11):1586-91. PubMed ID: 11343206
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial.
Miro JM; Lopez JC; Podzamczer D; Peña JM; Alberdi JC; Martínez E; Domingo P; Cosin J; Claramonte X; Arribas JR; Santín M; Ribera E;
Clin Infect Dis; 2006 Jul; 43(1):79-89. PubMed ID: 16758422
[TBL] [Abstract][Full Text] [Related]
6. A preliminary study of the frequency of focal neurological deficits in HIV/AIDS patients seropositive for Toxoplasma gondii IgG in Lagos, Nigeria.
Oshinaike OO; Okubadejo NU; Ojini FI; Danesi MA
Nig Q J Hosp Med; 2010; 20(3):104-7. PubMed ID: 21033315
[TBL] [Abstract][Full Text] [Related]
7. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
[TBL] [Abstract][Full Text] [Related]
9. Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virus.
Leport C; Franck J; Chene G; Derouin F; Ecobichon JL; Pueyo S; Miro JM; Luft BJ; Morlat P; Dumon H;
Clin Diagn Lab Immunol; 2001 May; 8(3):579-84. PubMed ID: 11329461
[TBL] [Abstract][Full Text] [Related]
10. Impaired in vitro lymphocyte response to toxoplasma antigen in HIV1 infected patients.
Derouin F; Rabian-Herzog C; Ballet JJ
J Clin Lab Immunol; 1989 Apr; 28(4):179-82. PubMed ID: 2628579
[TBL] [Abstract][Full Text] [Related]
11. Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART.
Tamarit A; Alberola J; Mir A; Benet I; Mira JV; Muñoz C; Galindo MJ; Navarro D
J Clin Virol; 2004 Apr; 29(4):308-14. PubMed ID: 15018860
[TBL] [Abstract][Full Text] [Related]
12. Biopsy-proven immune reconstitution syndrome in a patient with AIDS and cerebral toxoplasmosis.
Pfeffer G; Prout A; Hooge J; Maguire J
Neurology; 2009 Jul; 73(4):321-2. PubMed ID: 19636053
[No Abstract] [Full Text] [Related]
13. HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines.
Gazzinelli RT; Bala S; Stevens R; Baseler M; Wahl L; Kovacs J; Sher A
J Immunol; 1995 Aug; 155(3):1565-74. PubMed ID: 7636218
[TBL] [Abstract][Full Text] [Related]
14. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
[TBL] [Abstract][Full Text] [Related]
15. [Dynamics of T lymphocyte subsets in HAART treated AIDS patients with successful suppression of HIV replication and different CD4 + T cell restoration].
Qiu ZF; Li TS; Ruan GR; Han Y; Xie J; Zuo LY; Li YL; Wang AX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):386-90. PubMed ID: 16900640
[TBL] [Abstract][Full Text] [Related]
16. In-vitro synthesis of antibodies to Toxoplasma gondii by lymphocytes from HIV-1-infected patients.
Vendrell JP; Reynes J; Huguet MF; Ngou J; Michard C; Atoui N; Pratlong F; Segondy M; Serre A
Lancet; 1993 Jul; 342(8862):22-3. PubMed ID: 8100291
[TBL] [Abstract][Full Text] [Related]
17. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
[TBL] [Abstract][Full Text] [Related]
18. Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy.
Kesselring A; Gras L; Smit C; van Twillert G; Verbon A; de Wolf F; Reiss P; Wit F
Clin Infect Dis; 2011 Jun; 52(12):1458-65. PubMed ID: 21628488
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of human cytomegalovirus (HCMV)-specific CD4+ T cell frequency by cytokine flow cytometry as a possible indicator for discontinuation of HCMV secondary prophylaxis in HAART-treated AIDS patients.
Lilleri D; Piccinini G; Genini E; Comolli G; Chiesa A; Tordato F; Sotgiu G; Parisi A; Baldanti F; Revello MG; Gerna G
J Clin Virol; 2004 Apr; 29(4):297-307. PubMed ID: 15018859
[TBL] [Abstract][Full Text] [Related]
20. Toxoplasma encephalitis in an HIV-infected patient on highly active antiretroviral therapy despite sustained immune response.
Atreya AR; Arora S; Gadiraju VT; Martagon-Villamil J; Skiest DJ
Int J STD AIDS; 2014 Apr; 25(5):383-6. PubMed ID: 24108450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
